Dr. Steven M. Horwitz

Dr. Steven M. Horwitz, MD, is a medical oncologist specializing in the care of patients with lymphoma at Memorial Sloan Kettering Cancer Center. He brings clinical expertise across all types of lymphomas, with a particular focus on several less-common and challenging subtypes. His practice is dedicated to providing comprehensive, specialized care to patients navigating complex lymphoma diagnoses.

Dr. Horwitz's research program is centered on developing a deeper understanding of novel therapies for uncommon lymphoma subtypes, including T cell lymphomas, cutaneous lymphomas, Hodgkin disease, and post-transplant lymphoproliferative disorders (PTLD), which arise in immunosuppressed patients following organ transplant. His work aims to advance treatment options in areas where therapeutic progress has historically lagged, bringing new and more effective approaches to patients with these difficult-to-treat malignancies.

Through his combined commitment to clinical care and translational research, Dr. Horwitz continues to shape the landscape of lymphoma treatment. His focus on underserved and complex lymphoma populations reflects a dedication to improving outcomes for patients who have limited established treatment options, and he remains an active contributor to advancing the field through his investigations into emerging therapies.